Prevalence and predictors of germline BRCA1 and BRCA2 mutations among young patients with breast cancer in Jordan

BRCA1 and BRCA2 mutations are not uncommon in breast cancer patients. Western studies show that such mutations are more prevalent among younger patients. This study evaluates the prevalence of germline mutations in BRCA1 and BRCA2 among breast cancer patients diagnosed at age 40 or younger in Jordan...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel-Razeq, Hikmat, Abujamous, Lama, Abunasser, Mahmoud, Edaily, Sara, Bater, Rayan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295261/
https://www.ncbi.nlm.nih.gov/pubmed/34290354
http://dx.doi.org/10.1038/s41598-021-94403-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295261/
https://www.ncbi.nlm.nih.gov/pubmed/34290354
http://dx.doi.org/10.1038/s41598-021-94403-1

Ejemplares similares